See more : Brahmaputra Infrastructure Limited (BRAHMINFRA.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Retractable Technologies, Inc. (RVP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Retractable Technologies, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Federal Agricultural Mortgage Corporation (AGM-PG) Income Statement Analysis – Financial Results
- Himalaya Shipping Ltd (HSHPO.XD) Income Statement Analysis – Financial Results
- Sesoda Corporation (1708.TW) Income Statement Analysis – Financial Results
- Blonder Tongue Laboratories, Inc. (BDR) Income Statement Analysis – Financial Results
- Haier Smart Home Co., Ltd. (QIHCF) Income Statement Analysis – Financial Results
Retractable Technologies, Inc. (RVP)
About Retractable Technologies, Inc.
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 43.60M | 94.82M | 188.38M | 81.86M | 41.80M | 33.27M | 34.49M | 29.83M | 29.55M | 34.52M | 30.79M | 33.64M | 32.10M | 36.22M | 38.98M | 27.90M | 26.29M | 25.32M | 24.24M | 21.52M | 19.08M | 20.32M | 16.15M | 9.64M |
| Cost of Revenue | 34.49M | 66.57M | 93.03M | 44.85M | 27.66M | 23.05M | 24.52M | 19.48M | 18.99M | 22.50M | 20.48M | 22.47M | 21.20M | 23.82M | 25.47M | 19.67M | 18.30M | 17.78M | 15.43M | 16.41M | 14.65M | 14.99M | 13.32M | 7.88M |
| Gross Profit | 9.11M | 28.25M | 95.35M | 37.01M | 14.14M | 10.22M | 9.97M | 10.34M | 10.57M | 12.02M | 10.31M | 11.18M | 10.90M | 12.40M | 13.52M | 8.23M | 7.99M | 7.55M | 8.81M | 5.11M | 4.42M | 5.33M | 2.82M | 1.76M |
| Gross Profit Ratio | 20.89% | 29.80% | 50.62% | 45.21% | 33.83% | 30.72% | 28.91% | 34.67% | 35.75% | 34.82% | 33.49% | 33.22% | 33.96% | 34.25% | 34.67% | 29.49% | 30.39% | 29.80% | 36.34% | 23.75% | 23.19% | 26.21% | 17.48% | 18.30% |
| Research & Development | 581.17K | 525.73K | 901.38K | 574.53K | 516.10K | 621.37K | 740.57K | 571.84K | 607.53K | 616.78K | 837.07K | 871.85K | 815.02K | 885.45K | 1.03M | 1.07M | 1.07M | 958.80K | 934.21K | 626.94K | 561.14K | 337.93K | 756.54K | 899.15K |
| General & Administrative | 14.31M | 24.04M | 17.38M | 8.30M | 6.43M | 6.78M | 8.35M | 8.80M | 9.33M | 9.60M | 10.99M | 10.02M | 10.74M | 14.26M | 18.81M | 12.77M | 16.86M | 13.30M | 10.75M | 12.48M | 9.77M | 8.58M | 0.00 | 0.00 |
| Selling & Marketing | 5.71M | 4.54M | 4.48M | 4.06M | 4.22M | 4.40M | 4.66M | 4.03M | 3.84M | 3.97M | 4.41M | 4.22M | 3.44M | 3.67M | 4.37M | 4.84M | 5,299.16B | 5.55B | 4.15B | 3.65M | 3.37M | 4.04M | 0.00 | 0.00 |
| SG&A | 20.01M | 28.58M | 21.86M | 12.36M | 10.65M | 11.18M | 13.01M | 12.82M | 13.17M | 13.56M | 15.40M | 14.24M | 14.18M | 17.93M | 23.19M | 17.61M | 16.86M | 13.30M | 10.75M | 12.48M | 9.77M | 8.58M | 8.78M | 10.37M |
| Other Expenses | 0.00 | -3.83M | -425.16K | 0.00 | 0.00 | 0.00 | 0.00 | 456.12M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 365.30M | 2,594.60B | 18.67B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.32M | 8.78M | 10.37M |
| Operating Expenses | 20.60M | 25.27M | 22.33M | 12.94M | 11.17M | 11.80M | 13.75M | 13.39M | 13.77M | 14.18M | 16.24M | 15.12M | 14.99M | 18.82M | 24.22M | 18.67M | 17.94M | 14.26M | 11.68M | 13.11M | 10.33M | 11.23M | 9.54M | 11.27M |
| Cost & Expenses | 55.09M | 91.84M | 115.36M | 57.79M | 38.83M | 34.86M | 38.27M | 32.88M | 32.76M | 36.68M | 36.72M | 37.58M | 36.19M | 42.63M | 49.68M | 38.34M | 36.24M | 32.04M | 27.11M | 29.52M | 24.98M | 26.22M | 22.86M | 19.15M |
| Interest Income | 1.45M | 9.95K | 780.00K | 2.26M | 351.17K | 144.12K | 65.70K | 26.52K | 24.92K | 33.94K | 38.94K | 47.00K | 62.60K | 32.32K | 57.60K | 855.69K | 1.87M | 1.98M | 1.37M | 475.12K | 44.55K | 10.04K | 51.94K | 204.20K |
| Interest Expense | 152.17K | 170.65K | 227.18K | 260.26K | 166.90K | 177.19K | 210.76K | 213.30K | 219.67K | 222.81K | 230.58K | 231.21K | 240.48K | 302.84K | 21.89K | 54.36K | 326.30K | 411.15K | 339.69K | 243.92K | 307.14K | 446.39K | 553.62K | 203.78K |
| Depreciation & Amortization | 7.53M | 4.60M | 1.26M | 832.07K | 852.08K | 886.81K | 834.95K | 872.87K | 858.39K | 1.07M | 1.28M | 1.34M | 1.31M | 1.52M | 1.40M | 1.40M | 1.43M | 1.43M | 1.37M | 1.29M | 1.31M | 1.33M | 1.20M | 938.57K |
| EBITDA | -1.24M | 9.94M | 76.44M | 27.17M | 4.18M | -289.26K | -2.88M | -2.61M | 5.40M | -1.05M | -4.61M | -2.56M | 2.98M | 4.04M | -11.84M | -8.19M | -6.66M | -3.31M | -137.09K | -8.00M | -4.59M | -4.58M | -5.52M | -8.57M |
| EBITDA Ratio | -2.84% | 8.01% | 39.84% | 33.18% | 9.99% | -1.65% | -8.34% | -7.21% | -7.87% | -3.04% | -14.97% | -7.60% | -8.46% | -13.44% | -23.72% | -29.36% | -32.39% | -20.88% | -6.23% | -377.94% | -96.83% | -8.75% | -34.17% | -88.87% |
| Operating Income | -11.49M | 2.99M | 72.60M | 24.07M | 2.97M | -1.32M | -3.78M | -3.51M | -3.21M | -2.16M | -5.93M | -3.94M | -4.09M | -6.78M | -13.30M | -10.44M | -9.95M | -6.71M | -2.88M | -8.00M | -5.90M | -6.39M | -6.71M | -10.45M |
| Operating Income Ratio | -26.35% | 3.15% | 38.54% | 29.40% | 7.11% | -3.97% | -10.95% | -11.76% | -10.85% | -6.25% | -19.27% | -11.71% | -12.74% | -18.72% | -34.11% | -37.44% | -37.83% | -26.51% | -11.87% | -37.17% | -30.94% | -31.45% | -41.58% | -108.33% |
| Total Other Income/Expenses | 2.57M | 6.02M | 2.36M | 2.00M | 184.27K | 236.78K | -145.07K | -642.89K | 7.53M | -188.87K | -191.64K | -184.21K | 5.52M | 8.64M | -2.56M | 801.33K | 1.54M | 1.57M | 1.03M | 74.87M | 13.62M | -436.36K | 0.00 | 734.79K |
| Income Before Tax | -8.92M | 5.16M | 74.95M | 26.07M | 3.16M | -1.35M | -3.92M | -3.69M | 4.32M | -2.35M | -6.12M | -4.12M | 1.43M | 2.22M | -13.26M | -9.64M | -8.40M | -5.15M | -1.84M | 66.87M | 7.71M | -6.83M | 0.00 | 0.00 |
| Income Before Tax Ratio | -20.45% | 5.44% | 39.79% | 31.85% | 7.55% | -4.07% | -11.37% | -12.38% | 14.63% | -6.80% | -19.89% | -12.25% | 4.46% | 6.14% | -34.02% | -34.57% | -31.96% | -20.33% | -7.61% | 310.70% | 40.43% | -33.60% | 0.00% | 0.00% |
| Income Tax Expense | -1.91M | 83.87K | 18.89M | 1.85M | 7.88K | -13.32K | -187.61K | 1.13K | 7.88K | 8.18K | 90.97K | 9.82K | 13.80K | -176.06K | -3.84M | 855.69K | -1.45M | -1.28M | -605.36K | 12.18M | 265.47K | 917.99K | 501.67K | 938.15K |
| Net Income | -7.01M | 5.08M | 56.06M | 24.22M | 3.15M | -1.34M | -3.74M | -3.69M | 4.31M | -2.35M | -6.21M | -4.13M | 1.42M | 2.40M | -9.42M | -9.64M | -6.95M | -3.87M | -1.24M | 54.69M | 7.45M | -6.83M | -7.22M | -10.44M |
| Net Income Ratio | -16.08% | 5.36% | 29.76% | 29.59% | 7.53% | -4.03% | -10.83% | -12.39% | 14.60% | -6.82% | -20.18% | -12.28% | 4.42% | 6.63% | -24.17% | -34.57% | -26.43% | -15.28% | -5.11% | 254.12% | 39.04% | -33.60% | -44.69% | -108.33% |
| EPS | -0.24 | 0.15 | 1.65 | 0.80 | 0.07 | -0.04 | -0.12 | -0.13 | 0.21 | -0.09 | -0.23 | -0.16 | 0.02 | 0.04 | -0.40 | -0.41 | -0.29 | -0.16 | -0.05 | 2.33 | 0.23 | -0.34 | -0.36 | -0.71 |
| EPS Diluted | -0.24 | 0.15 | 1.63 | 0.80 | 0.07 | -0.04 | -0.12 | -0.13 | 0.20 | -0.09 | -0.23 | -0.16 | 0.02 | 0.04 | -0.40 | -0.41 | -0.29 | -0.16 | -0.05 | 2.33 | 0.20 | -0.34 | -0.36 | -0.54 |
| Weighted Avg Shares Out | 29.94M | 32.90M | 33.87M | 33.17M | 32.67M | 32.67M | 31.72M | 29.33M | 27.82M | 27.25M | 27.00M | 26.22M | 24.17M | 23.87M | 23.81M | 23.79M | 23.73M | 23.59M | 23.33M | 22.60M | 21.00M | 20.30M | 19.77M | 14.72M |
| Weighted Avg Shares Out (Dil) | 29.94M | 32.96M | 34.24M | 33.30M | 32.67M | 32.67M | 31.96M | 29.35M | 29.48M | 27.38M | 27.00M | 26.22M | 26.35M | 26.25M | 23.81M | 23.79M | 23.73M | 23.59M | 23.33M | 25.48M | 24.44M | 20.30M | 19.77M | 19.37M |
Retractable Technologies, Inc. Reports $23.4 Million in Operating Income for First Quarter Of 2021
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that its operating income was $23.4 million in the first quarter of 2021, compared to operating income for the same period last year of $481 thousand. In comparison, the annual...
Retractable Technologies, Inc. Declares Dividends to Series II Class B Convertible Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B Convertible Preferred Stock in the amount of $39,050. The dividend amount is $0.25...
Retractable Technologies, Inc. Reports Results For 2020
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2020. Further details concerning the results of operations as well as other matters are available in Retractable's Form 10-K filed...
Top Small-Cap Stocks for March 2021
These are the small-cap stocks with the best value, fastest growth, and most momentum for March 2021.
Retractable Technologies gets $54 million to supply syringes to the U.S. for COVID-19 vaccination
Retractable Technologies Inc. said in a securities filing on Feb. 16 that it was awarded a $54.2 million contract from the federal government. to supply low dead space safety syringes.
3 Stocks Warren Buffett Would Love
He's a stickler for predictable and recurring revenue.
These 3 Healthcare Stocks Are the Best Bets for 2021
Investing in the recovery from the pandemic could pay off big.
Retractable Technologies, Inc. Declares Dividends to Series I and II Class B Convertible Preferred Stock Shareholders
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series I Class B and Series II Class B Convertible Preferred Stock in the amounts of $10,041...
These Were the 5 Best Medical Device Stocks of 2020
These companies made millions by developing equipment for life-saving care, and enriched shareholders too.
These 5 Small-Cap Healthcare Stocks Gained the Most in 2020
These stocks have made investors richer by posting explosive revenue growth or advancing significantly in high-impact programs.
Source: https://incomestatements.info
Category: Stock Reports